Q: hi, would you consider these more on the risky side, or just smaller cap? I read Hammond EPS around 15 which seems fine to me. I can't find an EPS on LMN?
is this a decent entry point for each? if not, what price would be a more reasonable entry point?
cheers, Chris
Q: May I have your latest thoughts on QS? Do think the latest test results from Volkswagen to be positive? Do you expect QS will need to raise more capital by issuing more shares? I’m curious why the stock is listed on the NYSE instead of the NASDAQ. Are the listing costs similar?
Thanks,
Jim
Q: after the recent reverse split and additional financing, how many total shares are now outstanding and what % owned by insiders if available. Thanks
Q: Are there niche radio station companies out there worth pursuing? CJR.b:CA is an apparent "turkey" in Canada but does SGA:US merit some further research? Are there others?
Q: I have owned Theratechnologies since 2018 and watched this stock fall since I purchased it. The stock has been rising the last few weeks and was up 23% on Friday. I couldn't find any exciting press releases that would explain the increase. Do you know of any reason for the recent increase?
The 5 analysts listed on Qtrade have a price target of anywhere from $5.50-$12.04. How much faith can we put in the price targets of analysts?
I was quite excited that it was up to $3.03 but just noticed there was a 4 for 1 stock split in August 2023 so my 700 shares are now only 175 shares. So rather than being down 60% I am actually down 90%. Yikes, I better not tell my wife about this trade!
My holdings in TH are only worth $530 now. Should I sell this loser now or is it worth waiting until the annual report (November year end) comes out?
Q: Can you recommend any small or medium cap, US dollar denominated ETFs, that don’t have any dividends, phantom dividends, ROC, etc? Only looking for a capital gain/loss.
Q: I have small positions in TOI, NVEI, SIS, TOY and WELL in a TFSA, and am considering
adding to one of these.
Please rate these stocks in terms of growth prospects and indicate how much patience might be required.
Thanks.
Q: Hello,
Happy New Year; is Electrovaya worth stepping into or is it still too risky? Knight seems to have perked up a bit. Is the launch of the drug causing the small surge and is it something noteworthy or will this be another slow rise and than fall back to the 5 dollar level? Much appreciated.
Q: Montrose Env in NY provides environmental services. It was $76 about 15 months ago and now around $30. Can you give my your assessment on this small cap (0.8B) has a 15.9 P/E. Q3-2023 total revenue was $168 which Q3-2022 was $ 130. They appear to have had losses each of the past few years. It appears to have gone public mid-2020. I'd be grateful for your views on this small cap stock.
Q: I bought True North just before the split and it looks to me like it's up 45% in just over a month since the split. Am I misreading this? If this is correct, should I take profits?